BioCryst Pharmaceuticals, Inc. (BMV:BCRX)

BioCryst Pharmaceuticals Statistics

Total Valuation

BMV:BCRX has a market cap or net worth of MXN 28.60 billion. The enterprise value is 37.49 billion.

Market Cap	28.60B
Enterprise Value	37.49B

Important Dates

The next estimated earnings date is Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	209.92M
Shares Outstanding	n/a
Shares Change (YoY)	+3.62%
Shares Change (QoQ)	+2.15%
Owned by Insiders (%)	1.06%
Owned by Institutions (%)	92.03%
Float	196.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.79
PS Ratio	2.72
PB Ratio	-3.60
P/TBV Ratio	n/a
P/FCF Ratio	96.24
P/OCF Ratio	90.19
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.27, with an EV/FCF ratio of 126.14.

EV / Earnings	-55.67
EV / Sales	3.62
EV / EBITDA	33.27
EV / EBIT	36.42
EV / FCF	126.14

Financial Position

The company has a current ratio of 2.25

Current Ratio	2.25
Quick Ratio	1.98
Debt / Equity	n/a
Debt / EBITDA	12.17
Debt / FCF	46.88
Interest Coverage	0.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	7.46%
Return on Invested Capital (ROIC)	10.01%
Return on Capital Employed (ROCE)	19.81%
Revenue Per Employee	18.13M
Profits Per Employee	-1.16M
Employee Count	580
Asset Turnover	1.20
Inventory Turnover	39.36

Taxes

In the past 12 months, BMV:BCRX has paid 66.32 million in taxes.

Income Tax	66.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.34%
50-Day Moving Average	250.57
200-Day Moving Average	n/a
Relative Strength Index (RSI)	43.93
Average Volume (20 Days)	541

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.29

Income Statement

In the last 12 months, BMV:BCRX had revenue of MXN 10.51 billion and -673.45 million in losses. Loss per share was -3.36.

Revenue	10.51B
Gross Profit	6.99B
Operating Income	1.05B
Pretax Income	-607.12M
Net Income	-673.45M
EBITDA	1.10B
EBIT	1.05B
Loss Per Share	-3.36

Balance Sheet

The company has 4.90 billion in cash and 13.93 billion in debt, giving a net cash position of -9.03 billion.

Cash & Cash Equivalents	4.90B
Total Debt	13.93B
Net Cash	-9.03B
Net Cash Per Share	n/a
Equity (Book Value)	-7.95B
Book Value Per Share	-37.88
Working Capital	4.17B

Cash Flow

In the last 12 months, operating cash flow was 317.14 million and capital expenditures -19.91 million, giving a free cash flow of 297.22 million.

Operating Cash Flow	317.14M
Capital Expenditures	-19.91M
Free Cash Flow	297.22M
FCF Per Share	n/a

Margins

Gross margin is 66.48%, with operating and profit margins of 9.95% and -6.41%.

Gross Margin	66.48%
Operating Margin	9.95%
Pretax Margin	-5.77%
Profit Margin	-6.41%
EBITDA Margin	10.49%
EBIT Margin	9.95%
FCF Margin	2.83%

Dividends & Yields

BMV:BCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.62%
Shareholder Yield	-3.62%
Earnings Yield	-2.35%
FCF Yield	1.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:BCRX has an Altman Z-Score of -2.05 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.05
Piotroski F-Score	6